3CLogic to Showcase its ServiceNow Certified Integration at Knowledge18
Apr 10, 2018 07:00 am UTC| Business
ROCKVILLE, Md., April 10, 2018 -- 3CLogic, a leading cloud communications platform provider for enterprise businesses, today announced it is a Silver sponsor of the ServiceNow Knowledge18 conference, the largest...
CloudCommerce Appoints New Head of Parscale Digital
Apr 10, 2018 07:00 am UTC| Business
SANTA BARBARA, Calif., April 10, 2018 -- CloudCommerce, Inc. (OTCQB:CLWD), a leading provider of data driven marketing solutions, today announced that it has appointed Adam Brecht to serve as President of its flagship...
ADVA and Amartus demo automated service lifecycle management using MEF 3.0 architecture
Apr 10, 2018 06:30 am UTC| Business
PoC built on ADVA Pro-Vision® opens the door to streamlined operations and accelerated service activation Paris, France. April 10, 2018. ADVA (FSE: ADV) today announced a joint demo with Amartus that reveals how...
Ahold Delhaize share buyback update
Apr 10, 2018 06:01 am UTC| Business
Zaandam, the Netherlands, April 10, 2018 - Ahold Delhaize has repurchased 1,417,107 of Ahold Delhaize common shares in the period from April 3, 2018 up to and including April 6, 2018. The shares were repurchased at an...
Deinove introduces Phyt-N-Resist, the first pure phytoene for skincare
Apr 10, 2018 06:01 am UTC| Business
DEINOVE INTRODUCES PHYT-N-RESIST®, THE FIRST PURE PHYTOENE FOR SKINCARE Deinove scientific platform has designed an exclusive Deinococcus fermentation process to deliver the first pure Phytoene for application in the...
Oscilloquartz timing toolkit excels in EANTC interoperability tests
Apr 10, 2018 06:01 am UTC| Business
Highly agile OSA 5421 provides precise phase synchronization for LTE-A services over multi-vendor legacy networks Paris, France. April 10, 2018. Oscilloquartz, an ADVA (FSE: ADV) company, today announced that the...
Motif Bio Reports Fiscal Year 2017 Results
Apr 10, 2018 06:00 am UTC| Business
NEW YORK, April 10, 2018 -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced financial results for the year ended December...